Toragen Key Start-Up Accomplishments

  • $1.4 million of Angel and Seed Capital raised
  • UCSD PCT Patent filed
  • Technology Licensed from UCSD
  • Developed Regulatory Strategy
  • Met with FDA in pre-IND Meeting
  • FDA agreed to a ‘Fast Track’ 505(b)(2) Strategy
  • GMP Active Product Ingredient Manufactured
  • Pre-formulation completed
  • Filed a Second Patent on Proprietary Technology
  • Ready to begin Phase I Clinical Trial with Funding
%d bloggers like this: